FDA approves Lupin’s Corgard generic

SILVER SPRING, Md. — The Food and Drug Administration has approved Lupin’s generic version of Corgard (nadolol) tablets. The drug is indicated to manage patients with angina pectoris and to treat hypertension.

Lupin’s generic will be available in 20-, 40- and 80-mg dosage strengths. The drug had U.S. sales of $109.8 million for the 12 months ended June 2017, according to QuintilesIMS data.